Literature DB >> 19308953

Face resurfacing using a cervicothoracic skin flap prefabricated by lateral thigh fascial flap and tissue expander.

Qingfeng Li1, Tao Zan, Bin Gu, Kai Liu, Guoxiong Shen, Yun Xie, Rui Weng.   

Abstract

BACKGROUND: Resurfacing of facial massive soft tissue defect is a formidable challenge because of the unique character of the region and the limitation of well-matched donor site. In this report, we introduce a technique for using the prefabricated cervicothoracic skin flap for facial resurfacing, in an attempt to meet the principle of flap selection in face reconstructive surgery for matching the color and texture, large dimension, and thinner thickness (MLT) of the recipient. MATERIALS: Eleven patients with massive facial scars underwent resurfacing procedures with prefabricated cervicothoracic flaps. The vasculature of the lateral thigh fascial flap, including the descending branch of the lateral femoral circumflex vessels and the surrounding muscle fascia, was used as the vascular carrier, and the pedicles of the fascial flap were anastomosed to either the superior thyroid or facial vessels in flap prefabrication. A tissue expander was placed beneath the fascial flap to enlarge the size and reduce the thickness of the flap.
RESULTS: The average size of the harvested fascia flap was 6.5 x 11.7 cm. After a mean interval of 21.5 weeks, the expanders were filled to a mean volume of 1,685 ml. The sizes of the prefabricated skin flaps ranged from 12 x 15 cm to 15 x 32 cm. The prefabricated skin flaps were then transferred to the recipient site as pedicled flaps for facial resurfacing. All facial soft tissue defects were successfully covered by the flaps. The donor sites were primarily closed and healed without complications. Although varied degrees of venous congestion were developed after flap transfers, the marginal necrosis only occurred in two cases. The results in follow-up showed most resurfaced faces restored natural contour and regained emotional expression.
CONCLUSION: MLT is the principle for flap selection in resurfacing of the massive facial soft tissue defect. Our experience in this series of patients demonstrated that the prefabricated cervicothoracic skin flap could be a reliable alternative tool for resurfacing of massive facial soft tissue defects. (c) 2009 Wiley-Liss, Inc. Microsurgery, 2009.

Entities:  

Mesh:

Year:  2009        PMID: 19308953     DOI: 10.1002/micr.20640

Source DB:  PubMed          Journal:  Microsurgery        ISSN: 0738-1085            Impact factor:   2.425


  6 in total

1.  Microdissected Prefabricated Flap: An Evolution in Flap Prefabrication.

Authors:  Süleyman Taş
Journal:  Arch Plast Surg       Date:  2016-11-18

2.  Tubularized urethral reconstruction using a prevascularized capsular tissue prelaminated with buccal mucosa graft in a rabbit model.

Authors:  Hai-Lin Guo; Zhi-Ming Jia; Lin Wang; Xing-Qi Bao; Yi-Chen Huang; Jun-Mei Zhou; Hua Xie; Xiu-Jun Yang; Fang Chen
Journal:  Asian J Androl       Date:  2019 Jul-Aug       Impact factor: 3.285

3.  Perfect combination of the expanded flap and 3D printing technology in reconstructing a child's craniofacial region.

Authors:  Yanni Wang; Hongyan Qi
Journal:  Head Face Med       Date:  2020-03-03       Impact factor: 2.151

Review 4.  Contemporary reconstruction after complex facial trauma.

Authors:  Matthew R Zeiderman; Lee L Q Pu
Journal:  Burns Trauma       Date:  2020-02-28

5.  Tissue expander capsule as an induced vascular bed to prefabricate an axial vascularized buccal mucosa-lined flap for tubularized posterior urethral reconstruction: preliminary results in an animal model.

Authors:  Hai-Lin Guo; Lin Wang; Zhi-Ming Jia; Xing-Qi Bao; Yi-Chen Huang; Jun-Mei Zhou; Hua Xie; Xiu-Jun Yang; Fang Chen
Journal:  Asian J Androl       Date:  2020 Sep-Oct       Impact factor: 3.285

Review 6.  Imaging for thinned perforator flap harvest: current status and future perspectives.

Authors:  Yi Min Khoong; Xin Huang; Shuchen Gu; Tao Zan
Journal:  Burns Trauma       Date:  2021-12-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.